the women's health ecosystem: 119 funding events ($432M disclosed) and 43 product launches over the last 90 days.
119 deals in window (4 prior), $432M disclosed.
- ARPA-H Commits Up to $90.7M to Replace 50-Year-Old Fetal Monitoring Technology · $91M · Grant/Non-dilutive
- Oblenio Bio Raises $62M to Advance Immune Reset Therapy for Autoimmune Diseases · $62M · Series B
- Cross-Border Impact Ventures Hits $58M First Close for Global Healthtech Fund · $58M · Series A
- Melinda French Gates Pivotal Ventures Backs Magnify Ventures 46.6 Million Fund II · $47M
- Corner Health Raises $32.5M for Nurse Practitioner-Owned Primary Care Practices · $33M · Series A
- Rejoni Secures 25 Million Dollars to Commercialize Juveena Hydrogel for Uterine Healing · $25M · Series B
119 funding events were recorded in the last 90 days, against 4 in the prior window. 24 disclosed an amount, totalling $432M, with a median of $6M and a largest round of $91M. Stage mix: Undisclosed stage 85, Grant/Non-dilutive 9, Seed 6, Pre-seed 4, Series B 4, Growth 4, M&A 2, Series A 2. Largest reported round: ARPA-H Commits Up to $90.7M to Replace 50-Year-Old Fetal Monitoring Technology.
43 launches, 352 new companies indexed.
- Galderma Faces FDA Setback for RelabotulinumtoxinA While Kimball Expands CDMO Infrastructure
- BrightGene Prepares Global Launch for Obesity Drug Following Positive Phase 3 China Data
- Anthropic Signals Shift to Deep Science with Specialized Claude Science AI Model
- Echelon Debuts AI Workout Builder to Bridge Home and Commercial Fitness Segments
- Fountain Life lowers entry barriers to longevity medicine with BASE membership launch
43 product launches, 33 policy events, and 352 newly indexed companies fall inside the window. New companies cluster in Care Infrastructure (41), Consumer (36), News (29), Fertility (28), Metabolic (24), Diagnostics (24).